Could a simple injection help transplant patients avoid rejection?
NCT ID NCT02739412
First seen Jan 14, 2026 · Last updated May 15, 2026 · Updated 12 times
Summary
This study tested whether very low doses of a protein called IL-2, given as under-the-skin injections for 4 weeks, could increase the number of helpful immune cells (Tregs) in liver transplant recipients. The goal was to see if this approach might improve the body's acceptance of the new liver and reduce the need for strong anti-rejection drugs. Six adult patients who had received a liver transplant 2-4 years earlier took part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.